Forschung & Innovation
Publikationen

A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.

#2015

#Nature Communications

PMU Autor*in
Ravi Kalathur

Alle Autor*innen
Madhuri Kalathur, Alberto Toso, Jingjing Chen, Ajinkya Revandkar, Claudia Danzer-Baltzer, Ilaria Guccini, Abdullah Alajati, Manuela Sarti, Sandra Pinton, Lara Brambilla, Diletta Di Mitri, Giuseppina Carbone, R. Garcia-Escudero, Alessandro Padova, Letizia Magnoni, Alessia Tarditi, Laura Maccari, Federico Malusa, Ravi Kalathur, Lorenzo A Pinna, Giorgio Cozza, Maria Ruzzene, Nicolas Delaleu, Carlo V Catapano, Ian J Frew, Andrea Alimonti

Fachzeitschrift
Nature Communications

Kurzfassung

Keywords

EXPRESSION, PROSTATE-CANCER, EFFICACY, SURVEILLANCE, INHIBITOR, SUPPRESSOR, PROTEIN-KINASE CK2, CELL-CYCLE ARREST, PML, POTENT

Weitere Publikationen

#2026

#Originalarbeit

Mathias Ausserwinkler, Axel J. Hueber, Sophie Gensluckner, Bernhard Paulweber, Eugen Trinka, Patrick Langthaler, Bernhard Iglseder, Maria Flamm, Elmar Aigner, Bernhard Wernly Association between rheumatoid arthritis and depressive symptoms, INFLAMMATION; DEPRESSION; Rheumatoid arthritis; Mental Health; Population-based study; Somatic comorbidity;

#2026

#Editorial

Bram Tilburgs, Heidi Lindroth, Peter Nydahl Virtual reality in ICU delirium care, UNIT;

#2026

#Originalarbeit

Noel Spoelder, Tom D. Turmezei, Dimitri A. Kessler, James W. Mackay, Simon C. Mastbergen, Marcel Karperien, Mylene P. Jansen, Felix Eckstein Sex-related differences in femorotibial cartilage thickness, OSTEOARTHRITIS; KNEE; CARTILAGE THICKNESS; 3d mri; Sex-related differences;

Zurück zur Übersicht

Paracelsus Medizinische Privatuniversität Forschung & Innovation Publikationen

A chemogenomic screening identifies CK2 as a...